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ABSTRACT: Data mining techniques provide a popular and powerful tool set to gener-
ate various data-driven classification systems. In this paper, we investigate the com-
bined use of self-organizing maps (SOM) and nonsmooth nonconvex optimization
techniques in order to produce a working case of a data-driven risk classification
system. The optimization approach strengthens the validity of SOM results, and the
improved classification system increases both the quality of prediction and the homo-
geneity within the risk groups. Accurate classification of prostate cancer patients into
risk groups is important to assist in the identification of appropriate treatment paths.
We start with the existing rules and aim to improve classification accuracy by identi-
fying inconsistencies utilizing self-organizing maps as a data visualization tool. Then,
we progress to the study of assigning prostate cancer patients into homogenous groups
with the aim to support future clinical treatment decisions. Using the case of prostate
cancer patients grouping, we demonstrate strong potential of data-driven risk classi-
fication schemes for addressing the risk grouping issues in more general organiza-
tional settings.
KEY WORDS AND PHRASES: classification, data mining, optimization, prostate cancer,
risk grouping.
DATA MINING TECHNIQUES HAVE SHOWN great promise in the area of clinical decision
support, and in particular, cancer diagnosis and prognostics. For example, Mangasarian
et al. [15] discuss the applications of linear programming to the problem of clinical
classification of patients with breast cancer. Bellazi et al. [5] present the use of data
mining tools to derive a prognostic model of the outcome of resectable hepatocellular
carcinoma. Land et al. [12] discuss a new neural network technology developed to
improve the diagnosis of breast cancer using mammogram findings, whereas Walter
and Mohan [17] describe ClaDia, a learning classifier system applied to the well-
studied Wisconsin breast cancer data set. As far as prostate cancer is concerned, Zupan
et al. [19] propose a schema that enables the use of classification methods, including
machine learning classifiers, for survival analysis of prostate cancer patients, whereas
Zhang and Zhang [18] develop and validate ProstAsure—a neural network-derived
algorithm that analyzes the profile of multiple serum tumor markers and produces a
single-valued diagnostic index for early detection of prostate cancer.
Most of the different approaches to the problem of clustering analysis suggested in
the literature are mainly based on statistical, neural network, and machine learning
techniques. An excellent survey of existing approaches is provided in Jain et al. [8].
At the same time, there are relatively few attempts to utilize optimization techniques
for this purpose [14].
Bagirov et al. [4] propose the global optimization approach to clustering and dem-
onstrate how the supervised data classification problem can be solved via clustering.
The objective function in this problem is both nonsmooth and nonconvex and has a
large number of local minimizers. Problems of this type are quite challenging for
general-purpose global optimization techniques. Due to a large number of variables
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and the complexity of the objective function, general-purpose global optimization
techniques, as a rule, fail to solve such problems. It is very important, therefore, to
develop optimization algorithms that allow the decision-maker to find "deep" local
minimizers of the objective function. Such "deep" local minimizers provide a good
enough description of the data set under consideration as far as clustering is con-
cerned. The optimization algorithm discussed in this paper belongs to this type and is
based on nonsmooth optimization techniques.
For many clinicians, however, it is still difficult to trust the decisions of an auto-
mated algorithm, and the importance of rules to explain the decisions is critical to the
acceptance of the data mining technology. Certainly, automated rule generation meth-
ods such as classification and regression trees (CART) are available to find rules
describing different (predefined) subsets of the data. When the data sample size is
limited though, such approaches tend to find very accurate rules that apply to only a
small number of patients, who are frequently outliers. Clinicians are unlikely to trust
rules generated under these conditions, particularly when existing classification rules
are based on expert clinical knowledge.
In Schwarz et al. [16], it was demonstrated that data mining techniques can play an
important role in rule refinement, even if the sample size is limited. Instead of using
directed knowledge discovery (supervised learning methods) to generate rules or
models to assign prostate cancer patients into risk-homogeneous patient groups,
Schwarz et al. [16] propose to use undirected knowledge discovery (unsupervised
learning methods) to group the patients, explore the existing rules, and identify pos-
sible inconsistencies and refinements. A data visualization approach was required,
and the self-organizing maps (SOM) [6,9,10] were used to achieve alternative group-
ings of patients and explore the consistency of the risk classifications.
The objective of this paper is to expand the findings presented by Churilov et al. [6]
by comparing and complementing them with those presented by Schwarz et al. [16].
As a by-product, we provide a convincing illustration of the complex and integrated
nature of a real data mining project by demonstrating that imaginative combined use
of different data mining methodologies makes such a project a success.
Data Description and Existing Risk Groupings
THE WILLIAM BUCKLAND RADIOTHERAPY CENTER ( W B R C ) in metropolitan
Melbourne, Australia, had been selecting the prostate cancer patients for various treat-
ment approaches using risk groupings derived from a review of published predictive
models as shown in Table 1. Patients' diagnostic statistics used in this case study in-
cludes pathology Gleason Score (1 - best, 10 = worst), tumor stage (la = best, 4 =
worst), and the PSA (biochemical prostate-specific antigen) level at the time of diag-
nosis, as well as patient's age. The database consists of 258 de-identified records of
hormone-naive patients who underwent external beam radiotherapy at some stage be-
tween January 1,1990, and December 31,1997.As part of clinical and PSAfollow-up
that happened at 3, 6, 9, 12, 18, and 24 months, and then annually, the biochemical
(PSA) failure-free survival (bFFS) was calculated from the beginning of radiotherapy
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Table 1. WBRC Risk Group Classification
Risk group
Low
Intermediate
High
Gleason
score
2-6
2-6
2-6
7
2-7
2-7
8-10
Tumor
stage
T1c-2a
T1c-2a
T2b-3a
Up to T3a
Up to T3a
T3b-4
Any
PSA
0-10
>10-20
0-20
0-20
>20
Any
Any
Five-year
bFFS
(percent)
76.2
53.4
37.8
until the biochemical failure. Biochemical (PSA) failure was defined as per ASTRO
consensus [ 1 ] statement or any event that prompted androgen deprivation therapy.
Specifically, PSA failure is defined as three successively increasing PSA measures
during the follow-up checks after treatment, and is seen as an early indicator that
treatment has been unsuccessful. We use PSA failure here as a proxy measure for
survivability, since it can be detected earlier and correlates strongly with the bFFS
measure. The concept of risk in this situation is directly linked to the chance of a
bFFS over a given period of time (usually, five years)—that is, the higher the chance
of biochemical (PSA) failure-free survival for a given patient, the lower is the corre-
sponding clinical risk, and the less aggressive is the clinical treatment strategy that
can be implemented.
Applying the rules shown in Table 1 to the initial data set, it becomes apparent that
according to WBRC classification, 8.2 percent of all the patients belong to the "low-
risk" group, 51.6 percent belong to the "intermediate-risk" group, and the remaining
38.3 percent of the patients belong to the "high-risk" group. These findings are sum-
marized in Table 2. Note that this classification presents a relatively high percentage
of patients in the "intermediate" group, thus complicating the decisions regarding
appropriate treatment for many patients.
It is important to note that, as indicated in Table 1, the classification based on three
aggregated groups is derived by applying seven rules. If all the seven rules are al-
lowed to generate their corresponding risk groups. Table 3 can be obtained.
Note that separating the data into seven groups according to the rules used by WBRC
reveals one very important inconsistency specifically demonstrating that the bFFS
rate for the group High2 is, in fact, higher than the bFFS rate for the group Intermedi-
ate3. This directly contradicts the way the concept of clinical risk is intuitively de-
fined, and raises the question of the appropriateness of the set of rules used by the
WBRC to identify specific risk groups. Note also that this classification, though stipu-
lating better "granularity" of risk groups, is fundamentally based on the set of (some-
times inappropriate) rules reported in the literature rather than "data-driven" rules
that are elicited from the practical history observed in WBRC.
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Table 2. WBRC Risk Group
Five-year bFFS (percent)
Percent of records
Classification with Relative Sizes of the Groups
Low
risk
76.2
8.2
Intermediate
risk
53.4
51.2
' High
risk
37.8
38.3
Table 3. Rule-Based Seven Groups Classification of WBRC Data
Risk groups Low
Five-year bFFS
(percent) 76
Percent of records 8.2
Intl
68
10.9
Int2 Int3
65 41
14.5 25.8
Highl High2
31 56
20.3 6.3
High3
40
11.7
Adopting a data-driven perspective on WBRC classification, we aim to improve the
accuracy of the rules as applied to the WBRC patient database. It is important to note
that the natural desire of a clinical decision-maker is to ensure that the classification
rules ensure the following two conditions are met as closely as possible:
• the PSA failure measure for "high-risk" group should be high, whereas that for
the "low-risk" group should be low, if the classification rules are accurate; and
• the size of the "intermediate-risk" group is minimal, thus making sure that the
patient is either a "high-risk" or a "low-risk" one in order to make the future
treatment decision as tightly linked to the patient's risk attribute as possible.
These two conditions provide the decision-maker with two objectives that are not
necessarily mutually attainable, and can even be conflicting.
Methodology
IT IS IMPORTANT TO NOTE THAT AT THE FIRST STAGE, we are proposing a methodology
for exploring for identifying inconsistencies in the existing rules, rather than generat-
ing a completely new set of rules. It is our hypothesis that, although the existing rules
are clinically meaningful, the accuracy of the WBRC patient database could be im-
proved by refining them.
It should be noted that the existing rules make no reference to patient age, but this
data is readily available and believed to be important to patient survivability. Clearly,
there is room for improvement in the existing rules, by searching for the role of age in
the classification structure, and exploring the boundaries of the existing rules.
At the first stage of this study, we use an undirected knowledge discovery ap-
proach (SOM) to explore the appropriateness of the rules across different segments
of the patient database. Then, at the second stage, the optimization-based algorithm
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for clustering patients into homogenous groupings as far as their survivability is
concerned is applied and the corresponding results are validated, compared, and
contrasted.
Self-Organizing Maps
SOMs [7, 10, 11, 13] are the best-known unsupervised neural network approach to
clustering. Their advantage over traditional clustering techniques, such as the fc-means
algorithm [8], lies in the improved visualization capabilities resulting from the two-
dimensional map of the clusters. Often, patterns in a high-dimensional input space
have a very complicated structure, but this structure is made more transparent and
simple when they are clustered in a lower-dimensional feature space. Kohonen [10,
11 ] developed SOMs as a way of automatically detecting strong features in large data
sets. SOMs find a mapping from the high-dimensional input space to low-dimen-
sional feature space, so the clusters that form become visible in this reduced dimen-
sionality.
Since traditional clustering techniques find clusters within the input space, which is
typically high dimensional and difficult to visualize, the dimension reduction pro-
vided by the SOM by projecting the clusters onto a two-dimensional map is seen as
one of its main advantages. The software used to generate the SOMs is Viscovery
SOMine (www.eudaptics.com), which provides a colorful cluster visualization tool,
and the ability to inspect the distribution of different variables across the map [7].
The Nonsmooth Optimization Approach to Solving
Clustering Problems
The subject of cluster analysis is the unsupervised classification of data and discov-
ery of relationships within the data set without any guidance. The basic principle of
identifying these hidden relationships is that if input patterns are similar, they should
be grouped together. Two inputs are regarded as similar if the distance between these
two inputs (in multidimensional input space) is small.
With this notion in mind, consider set A, which consists of r n-dimensional vectors
a' = (a,',. .., aj), i-l,.. .,r, where n is the number of data fields/attributes. The aim
of clustering is to represent this set as the union of q clusters. Since each cluster can
be described by the location of its center, it is instrumental to locate a cluster's center
in order to adequately describe the cluster itself. Thus, we address the problem of
finding q points that serve as centers of corresponding clusters.
Consider now an arbitrary set X, consisting of q points x\ . .., x^. The distance
d{a', X) from a point a' that belongs to set A to set X is defined by
d(a',x)= min
where
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The deviation d{a', X) from set A to set X can be calculated using the formula
1=1
(3)
Thus, as far as optimization approach is concerned, the cluster analysis problem can
be reduced to the following mathematical programming problem
minf{x\...,x'']
where
mm
s=i ?"
If ^ > 1, the objective function/in problem (4) is nonconvex and nonsmooth. Note
that the number of variables in optimization problem (4) is ^ X n. If the number q of
clusters and the number n of data attributes are large, the decision-maker is facing a
large-scale global optimization problem. Moreover, the form of the objective func-
tion in this problem is complex enough to not become amenable to the direct applica-
tion of general-purpose global optimization methods. Therefore, in order to ensure
the practicality of the optimization approach to clustering, the proper identification
and use of local optimization methods with the special choice of a starting point is
very important. Clearly, such an approach does not guarantee the globally optimal
solution problem (4). On the other hand, this approach allows one to find a "deep"
minimum of the objective function, which, in turn, provides a good enough clustering
description of the data set under consideration.
Note also that the meaningful choice of the number of clusters is very important for
clustering analysis. It is diiFicult to define a priori how many clusters represent the set A
under consideration. In order to increase the knowledge-generating capacity of the re-
sulting clusters, the optimization-based approach discussed in this paper adopts the fol-
lowing strategy: starting from a small enough number of clusters q, the decision-maker
has to gradually increase the number of clusters for the analysis until certain termination
criteria motivated by the underlying decision-making situation are satisfied.
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As far as optimization is concerned, this means that if the solution of the corre-
sponding optimization problem (4) is not satisfactory, the number of clusters q should
be iteratively increased so that problem (4) should be solved with ^ -t-1 clusters, and
so on, until some termination criterion is met. This implies that one needs to solve
repeatedly arising global optimization problem (4) with different values of ^—a task
even more challenging than solving a single global optimization problem. In order to
avoid this difficulty, a step-by-step calculation of clusters is implemented in the opti-
mization algorithm discussed below.
It is also important to note that the form of the objective function in problem (4)
allows one to significantly reduce both the number of attributes (feature selection)
and the number of records in a data set. Although not essential in the case reported in
this paper, this ability proves very important for mining large data sets. The way the
proposed algorithm utilizes these features is discussed in detail in Bagirov et al. [4]
and Bagirov and Churilov [3].
The following optimization algorithm originally presented in Bagirov and Churilov
[3] is used to cluster the prostate cancer patients for the purposes of this study.
Optimization Algorithm for Clustering Analysis of Prostate Cancer Patients
Step 1—Initialization: Select a tolerance e > 0. Select an n-dimensional starting point
x° = (;c°,,..., x„°) and solve the following minimization problem:
| | | | s.t. xGSH". (6)
i=\
Let an ^-dimensional point x'* be a solution to this problem and / be the corre-
sponding objective function value. Set k=\.
Step 2—Computation of the next cluster: Select an n-dimensional vector x ,^ construct
a new 2n-dimensional starting point x°^  = (x'*, x°) and solve the following optimiza-
tion problem:
m i n / ( x ) s.t. xG9fl", (7)
where
Step 3: Let x*+'* be a solution to problem (7). Takex*° = (x'*,..., x**, x*+'*) as a new
starting point and solve the following minimization problem:
nun/ (x) s.t. XELW- ' , \°)
where
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(9)
Step4—Termination criterion: Let j ; * * ' • ' be a solution to problem (8) and/*'* be the
corresponding value of the objective function. If
717 *'^' (10)
then stop, otherwise seXk = k+ 1 and go to Step 2.
Both problems (7) and (8) are nonsmooth optimization problem, and the discrete
gradient method developed by Bagirov [2] is used to address these problems.
SOM Implementation and Analysis
As DESCRIBED IN THE PREVIOUS SECTION, at the first Stage, the SOMs were employed
to cluster the patients using four inputs (patient age, PSA at time of diagnosis, Gleason
score, and tumor stage). Once the clusters have formed, the distribution of other vari-
ables, such as PSAfailure and WBRC classification group, can be superimposed over
the clusters to identify any inconsistent regions.
Figure 1 shows the component planes of the four variables used to generate the
clusters (small maps at the bottom), and the superimposition of PSAfailure and WBRC
risk group number (1 - low, 2 = intermediate, 3 - high). The circled clusters show two
groups of patients. The upper cluster contains patients who have been classified as
intermediate by the existing rules, and yet the probability of PSA failure is actually
quite low. The average age of this group is 68.07 years. The lower cluster contains
patients who have been classified as intermediate by the existing rules, and yet the
probability of PSA failure is actually quite high. The average age of this group is 60.4
years. Clearly, when patient age is considered, two subsets of the intermediate-risk
group can be found with extremely different PSA failure probabilities. In fact, the
younger of these groups should be considered high risk, and patients in the older
cluster should be considered low risk, according to the superimposed PSA failure
statistics. Thus, the SOM has revealed a large group of patients labeled intermediate
risk by the existing rules, who should be reclassified. If we introduce a new rule to
split patients based on age greater than or less than 65, we find the accuracy improves.
A similar refinement of the existing rules is revealed when the SOM exercise is
repeated, but this time using PSA failure as an input along with the other four inputs.
The purpose of including PSA failure as an input is not to use the resulting map as a
predictive model of risk at the time of diagnosis (since PSA failure is not known until
many months or years after treatment), but rather to identify further inconsistencies
in the rules and the existing labels.
Figure 1 shows the component planes of the five variables used to generate the
clusters and the superimposition of WBRC risk group number. The circled region
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60.4
Figure L SOM Component Planes (Generated Using PSA, Gleason. Age. and Tumor Stage),
with Superimposed PSA Failure and WBRC Risk Group
contains a large number of patients currently classified as intermediate risk, and yet,
clearly, in the PSA failure negative region of the map. Inspecting the component
plane for the variable PSA (at time of diagnosis) reveals that these patients mostly
have an initial PSA measure of less than 12. Thus a new rule can be created that
classifies this subset of patients as low risk if PSA is less than 12.
Optimization-Based Grouping: Implementation and Analysis
APPLYING THE OPTIMIZATION ALGORITHM discussed in the previous section to the
WBRC prostate cancer data set with £ = 0.01 using the patient's age, Gleason score,
tumor stage, and PSA level at diagnosis as input parameters, 10 clusters are pro-
duced, as surtimarized in Table 4. Note that the "tumor stage" field was preprtx;essed
by converting it to the scale of I -8 , where score 1 represents tumor stage I a and score
8 represents tumor stage 4. The values reported represent the arithmetic mean (5),
minimum and maximum value of input parameters \m. M], and the coefficient of
variation K percent for all input parameters for every cluster obtained.
Note that clusters 2 and 3, which contain 2 and 6 records, respectively, are formed
due to unusually large readings of the PSA and represent statistical outliers of some
kind; but due to the nature of the problem domain, these clusters can hardly be ex-
cluded or ignored, as extreme values of some parameters (such as very high PSA
readings in relatively young patients) may suggest very intensive treatment options
for some patients.
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Table 5. Ten Clusters Produced by the Optimization Algorithm with
Corresponding bFFS Values
Cluster
Percent of
records
Five-year
bFFS (percent)
10
10
73
5
16
71
9
3
67
8
7
61
2
1
50
7
23
47
1
19
44
6
11
38
3
2
17
4
7
16
At the next stage of the study, the corresponding bFFS rates were calculated for
every cluster, as presented in Table 5 (note that the clusters are sorted in decreasing
order of bFFS readings).
In order to comply with the arrangements on risk assessment adopted in WBRC,
the percentage levels of five-year bFFS considered as boundaries between risk groups
were kept the same. According to these arrangements, clusters 10 and 5 represent the
low-risk group, clusters 6, 3, 4, and 1 clearly include high-risk patients, and the
remaining clusters include the patients with intermediate risk. Note that the bFFS
levels separation between clusters is much more pronounced than in the case of Table
3. This allows, for example, to closely investigate the patients from cluster 7, as they
are much more likely to be at the riskier end of the intermediate group than other
patients.
Discussion
THIS STUDY DEMONSTRATES THAT data mining techniques can play an important role
in rule refinement, even if the sample size is limited. Instead of using directed knowl-
edge discovery (supervised learning methods) to generate rules or models to assign
prostate cancer patients into risk-homogeneous patient groups, we propose to use un-
directed knowledge discovery (unsupervised learning methods) to group the patients,
explore the existing rules, and identify possible inconsistencies and refinements.
The refined rules, as depicted in Figure 2, have improved both the accuracy of the
high- and low-risk classifications, and reduced the number of patients in the interme-
diate-risk group. These two objectives were at first thought to be confiicting. Table 6
shows how the accuracy of the rules has been improved through the methodology of
initial inspection, identifying age of 65 as a significant boundary using SOM, and
identifying PSA of 12 as a significant boundary using another SOM. The first obser-
vation is that the percentage of patients classified in the intermediate-risk group has
been substantially reduced from 51.2 percent to 34.8 percent without significantly
affecting the accuracy of this class. The number of patients classified as low risk has
more than doubled (from 8.2 percent to 20.4 percent), whereas the accuracy of the
classification has improved (a reduction in the percentage of patients in the class who
have PSA failure). Clinically, this is a positive outcome, since these patients can avoid
unnecessary treatment. Similarly, the number of patients classified as high risk
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Figure 2. Tree Representation of Refined Rules, After Applying SOM to Reveal
Inconsistencies
Table 6. Accuracy and Coverage of Existing Rules and Improved Rules (in percent)
Low
Intermediate
High
Coverage
Existing
WBRC rules
PSA
failure Records
23.8 8.2
46.6 51.2
62.2 38.3
97.7
After SOM
PSA
failure
21.2
44.9
67.0
Records
20.4
34.8
44.9
100.0
After
optimization
PSA
failure
28.4
46.9
64.3
Records
26.2
34.4
39.4
100.0
has increased (from 38.3 percent to 44.9 percent), whereas the accuracy of their clas-
sification as high risk (as evidenced by PSA failure) has simultaneously improved
(from 62.2 percent to 67 percent having PSA failure).
As far as optimization-based clustering is concerned, in order to use the same baseline
for comparison, 10 clusters produced by the optimization algorithm should now be
aggregated into three groups, as summarized in Table 6.
Observe that, using the optimization-based clustering approach, both conditions 1
and 2 for an intuitively good classification discussed in the second section are satis-
fied. While the percentages of biochemical-failure-free survival (and, consequently.
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the measurements for PSA failure) are similar for the initial WBRC approach, SOM
clustering, and optimization-based clustering approaches, the resolution capacity of
both clustering approaches is definitely much higher. In particular, under SOM clas-
sification, 20 percent of patients are classified as low risk; for optimization-based
clustering this number is 26 percent, as opposed to 8 percent in the initial WBRC
classification—these findings are of extreme importance for clinical judgment, as for
a reasonably large number of elderly people they may mean lower dosage of radia-
tion therapy or the absence of other kinds of therapies with significant side effects.
Note also that the improvement in the low-risk group is obtained without any reduc-
tion effect on the high-risk group and only by the means of reducing the intermediate-
risk group.
Summary and Conclusions
THIS PAPER HAS SUCCESSFULLY DEMONSTRATED that both SOMs and optimization-
based clustering algorithms can be used to explore existing classification rules, devel-
oped by experts, and identify inconsistencies with a patient database. As the proposed
optimization algorithm calculates clusters step-by-step and the form of the objective
function allows the user to significantly reduce the number of instances in a data set,
it can be effectively utilized for clustering in large-scale data sets. Conducting a simi-
lar study on a much larger prostate cancer database would therefore allow us to over-
come some of the limitations of this study that are due to the modest size of the
WBRC database.
A rule-based classification system is important for the clinician to feel comfortable
with the decision. Certainly, a decision tree can be used to generate data-driven rules,
but as we have shown, for small sample sizes these rules tend to describe outliers that
do not necessarily generalize to larger data sets. The benefits of a more exploratory
approach to refining the existing rules, which clinicians are already comfortable with,
is clear. We have demonstrated that this approach has been able to improve the accu-
racy of the risk classifications, and reduce the number of patients in the intermediate-
risk group, assisting clinicians by providing clearer decisions regarding appropriate
treatment for more patients.
Overall, it is important to note that the human effect of this research is difficult to
overestimate. As the correct risk classification often means the absence/presence of
an extra type of an invasive therapy (often with multiple and strong side effects) a
given patient would have to undergo, even minor improvement in risk grouping has
direct and unambiguous effect on this patient's quality of life.
It is demonstrated that the proposed approach can support decision-making by im-
proving the accuracy of risk assessment, and it can, therefore, be seen as an evidence-
based predictive tool with high-knowledge-generation capabilities. The proposed
methodology enables the rules to be refined and improved, without radically altering
them beyond recognition. Note also that the suggested risk classification approach is
not in any way specific to the domain of clinical medicine. Classification problems of
a similar type frequently arise in broader organizational contexts, as the tasks of risk
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grouping customers, employees, goods, services, duties, and so on, become the part
of the everyday routine for all levels of organizational risk management. Decision
support functionality based on the suggested combination of computational tools has
a significant potential to enhance organizational information systems.
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